Furthermore, tumors from control mice were positive for the proliferation marker Ki67, whereas Ki67 staining was considerably decreased in tumors from the tCoa-NGR treated group (Fig. 6), which is in line with the significant reduction in tumor growth observed in these mice (Fig. 5a, b). This evidence concerns the gene MKI67 and neoplasm.